Brief: LENZ Therapeutics Announces FDA Acceptance Of New Drug Application For LNZ100 For The Treatment Of Presbyopia

LENZ Therapeutics

21/10/2024 13:38

Oct 21 (Reuters) - Lenz Therapeutics Inc  LENZ.O :
    * LENZ THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG
APPLICATION FOR LNZ100 FOR THE TREATMENT OF PRESBYOPIA
    * LENZ THERAPEUTICS INC - FDA ASSIGNS PDUFA TARGET ACTION
DATE OF
AUGUST 8, 2025 FOR LNZ100

Source text for Eikon:  ID:nGNX5TNcrx 
Further company coverage:  LENZ.O